Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

PROLOR and Yeda sign agreement for reversible PEGylation technology

Jan. 20, 2011

Johns Hopkins Brain Science Institute and Ortho-McNeil-Janssen enter collaboration

Jan. 20, 2011

Ironwood Pharma and Protagonist Therapeutics join to develop new peptide therapeutics

Jan. 20, 2011

Chugai grants Circadian Technologies global license to VEGF-D program

Jan. 19, 2011

Merck Serono and Domain Therapeutics join to develop agents for Parkinson's disease

Jan. 18, 2011

Galapagos provides update on arthritis alliance with GSK

Jan. 18, 2011

Epizyme and GSK join to develop agents targeting histone methyltransferases

Jan. 18, 2011

Lilly and Boehringer Ingelheim enter global diabetes alliance

Jan. 18, 2011

Dyax and Sigma-Tau expand agreement to commercialize Kalbitor

Jan. 17, 2011

Celtic Therapeutics acquires RX-10045 from Resolvyx Pharma

Jan. 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...